Pharma Companies Are Embracing Artificial Intelligence to enhance drug discovery, streamline clinical trials, optimize production, and personalize treatments. AI enables better decision-making, accelerates time-to-market, and boosts efficiency across the entire pharmaceutical value chain, revolutionizing the way the industry operates. This technological shift promises to unlock new opportunities for innovation and improved patient outcomes.Learn more at Eularis.
Beyond Failure Prevention: How AI is Redesigning the Drug Discovery Pipline
AI in drug development is moving beyond “failure prevention” into something much bigger: redesigning how we discover, develop, and deliver medicines. In this episode, Dr Andree Bates speaks with Vitalay Fomin of Numenos about biomarker discovery, patient stratification, and why the next breakthroughs come from breaking down data silos across diseases, modalities, and even species.



Write a comment ...